Creative Destruction: The Rise of Digital Innovations in Clinical Laboratories
Digital innovations are shifting the role of laboratory medicine and represent a new paradigm in standard of care.
Read MorePosted by Chris Wolski | Oct 27, 2022 | Digital Pathology |
Digital innovations are shifting the role of laboratory medicine and represent a new paradigm in standard of care.
Read MorePosted by Andy Lundin | Oct 24, 2022 | Emerging & Zoonotic Diseases |
GlycoPath’s proprietary technology was used to distinguish between Lyme disease infection states and track treatment response.
Read MorePosted by Andy Lundin | Oct 24, 2022 | Infectious Diseases |
The U.S. CDC states that antibiotic resistant infections are responsible for killing over a million people worldwide every year.
Read MorePosted by Chris Wolski | Oct 21, 2022 | Diagnostic Technologies |
Scientists developing a diagnostic tool that would use AI to speed the process of detecting biomarkers in biofluids have shown it could work.
Read MorePosted by Chris Wolski | Oct 14, 2022 | Emerging & Zoonotic Diseases, Immunoassay Reagents & test Kits |
US BioTek Laboratories is now offering Monkeypox Diagnostic Testing, utilizing a lesion swap specimen and RT-PCR testing.
Read More